LHCGR Antikörper (C-Term)
-
- Target Alle LHCGR Antikörper anzeigen
- LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LHCGR Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Human, Maus
- Produktmerkmale
-
Rabbit Polyclonal antibody to LHR (luteinizing hormone/choriogonadotropin receptor)
LHR antibody [C3], C-term - Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human LHR. The exact sequence is proprietary.
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: H1299
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
A Tri-fusion Reporter Mouse Reveals Tissue-Specific FGF1B Promoter Activity in vivo." in: Scientific reports, Vol. 9, Issue 1, pp. 11143, (2019) (PubMed).
: "The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes." in: Scientific reports, Vol. 7, pp. 39121, (2018) (PubMed).
: "
-
A Tri-fusion Reporter Mouse Reveals Tissue-Specific FGF1B Promoter Activity in vivo." in: Scientific reports, Vol. 9, Issue 1, pp. 11143, (2019) (PubMed).
-
- Target
- LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))
- Andere Bezeichnung
- luteinizing hormone/choriogonadotropin receptor (LHCGR Produkte)
- Synonyme
- HHG antikoerper, LCGR antikoerper, LGR2 antikoerper, LH/CG-R antikoerper, LH/CGR antikoerper, LHR antikoerper, LHRHR antikoerper, LSH-R antikoerper, ULG5 antikoerper, Gpcr19-rs1 antikoerper, LH-R antikoerper, Lhr antikoerper, LSHR antikoerper, lhr antikoerper, GTHR-II antikoerper, zfGTHR-II antikoerper, LHCGR antikoerper, LOC100222883 antikoerper, lh-r antikoerper, LOC100305044 antikoerper, luteinizing hormone/choriogonadotropin receptor antikoerper, luteinizing hormone/choriogonadotropin receptor L homeolog antikoerper, luteinizing hormone receptor antikoerper, LHCGR antikoerper, Lhcgr antikoerper, lhcgr antikoerper, lhcgr.L antikoerper, lhr antikoerper, LOC100305044 antikoerper
- Hintergrund
-
This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia.
Cellular Localization: Cell membrane, Multi-pass membrane protein - Molekulargewicht
- 79 kDa
- Gen-ID
- 3973
- UniProt
- P22888
- Pathways
- Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, cAMP Metabolic Process, Glycosaminoglycan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Autophagie, Negative Regulation of intrinsic apoptotic Signaling
-